At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
LCI-LUN-NSC-SBRT-001: Phase II Prospective Trial of Primary Lung Tumor Stereotactic Body Radiation Therapy Followed by Concurrent Mediastinal Chemoradiation and Adjuvant Immunotherapy for Locally-Advanced Non-Small Cell Lung Cancer
In Brief
A Phase 2 clinical trial evaluating SBRT, Carboplatin, and 5 other interventions for Lung Cancer Stage II and 2 related conditions. Active but no longer recruiting, targeting 61 participants across 1 site.
Detailed Summary
This is a single-arm, single-stage Phase II study designed to evaluate the 1-year PFS rate in subjects with locally-advanced NSCLC (stage II/III) and treated with Stereotactic Body Radiation Therapy (SBRT) followed by concurrent mediastinal chemoradiation with or without consolidation chemotherapy. A total of 60 subjects will be enrolled to this study over a 4 year accrual period.
Study Details
Timeline
Interventions
Primary tumor SBRT
concurrent chemotherapy
concurrent chemotherapy
concurrent chemotherapy
concurrent chemotherapy
mediastinal radiation
adjuvant immunotherapy